ISL
CELG

Ingalls & Snyder LLC’s Celgene Corp CELG Stock Holding History

Ingalls & Snyder LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-105,600
Closed -$10.5M – 450
2019
Q3 		$10.5M Sell
105,600
-1,602
-1% -$152K 0.51% 54
2019
Q2 		$9.91M Sell
107,202
-28,058
-21% -$2.66M 0.48% 57
2019
Q1 		$12.8M Buy
135,260
+4,862
+4% +$425K 0.61% 44
2018
Q4 		$8.36M Buy
130,398
+21,540
+20% +$1.59M 0.44% 59
2018
Q3 		$9.74M Sell
108,858
-24,652
-18% -$2.18M 0.41% 64
2018
Q2 		$10.6M Buy
133,510
+76,024
+132% +$6.31M 0.49% 55
2018
Q1 		$5.13M Buy
57,486
+255
+0.4% +$24.5K 0.25% 93
2017
Q4 		$5.97M Buy
57,231
+30,230
+112% +$3.41M 0.27% 82
2017
Q3 		$3.94M Buy
27,001
+486
+2% +$66.2K 0.21% 90
2017
Q2 		$3.44M Sell
26,515
-4,194
-14% -$514K 0.19% 92
2017
Q1 		$3.82M Buy
30,709
+6,003
+24% +$718K 0.2% 90
2016
Q4 		$2.86M Buy
24,706
+3,860
+19% +$430K 0.16% 104
2016
Q3 		$2.18M Sell
20,846
-1,320
-6% -$143K 0.12% 128
2016
Q2 		$2.19M Buy
22,166
+4,895
+28% +$506K 0.13% 121
2016
Q1 		$1.73M Buy
17,271
+1,668
+11% +$172K 0.11% 128
2015
Q4 		$1.87M Buy
15,603
+6,296
+68% +$728K 0.12% 121
2015
Q3 		$1.01M Sell
9,307
-54
-0.6% -$6.7K 0.07% 170
2015
Q2 		$1.08M Buy
9,361
+51
+0.5% +$5.83K 0.06% 171
2015
Q1 		$1.07M Sell
9,310
-1,600
-15% -$191K 0.06% 172
2014
Q4 		$1.22M Buy
10,910
+2,700
+33% +$285K 0.07% 160
2014
Q3 		$778K Buy
8,210
+400
+5% +$36.1K 0.04% 196
2014
Q2 		$670K Sell
7,810
-600
-7% -$45.6K 0.03% 219
2014
Q1 		$587K Sell
8,410
-340
-4% -$26.9K 0.03% 222
2013
Q4 		$739K Buy
8,750
+50
+0.6% +$3.96K 0.04% 199
2013
Q3 		$670K Hold
8,700
– – 0.04% 203
2013
Q2 		$508K Buy
+8,700
New +$524K 0.03% 227

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Ingalls & Snyder LLC's CELG Position: Q4 2019 in Review

Ingalls & Snyder LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 105,600 shares — an estimated $10.5M sold.

Ingalls & Snyder LLC first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $12.8M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ingalls & Snyder LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 105,600 Celgene Corp shares in Q4 2019, an estimated $10.5M.
  • Ingalls & Snyder LLC first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Ingalls & Snyder LLC's Celgene Corp position peaked at $12.8M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2019, filed 15 Jan 2020.